CLINICAL RESPONSE AND RADIOGRAPHIC PROGRESSION IN ANKYLOSING SPONDYLITIS PATIENTS UNDER ANTI-TNF THERAPY: IMPACT OF HIP INVOLVEMENT

被引：0
|
作者：
Shimabuco, A. Y. [1 ]
Milanez, F. M. [1 ]
Moraes, J. C. B. [1 ]
Perico, G. V. [2 ]
Goncalves, C. R. [1 ]
Waisberg, M. G. [1 ]
Sampaio-barros, P. D. [1 ]
Saad, C. G. S. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Div Rheumatol, Sao Paulo, Brazil
[2] Unidade Radiol Criciuma, Criciuma, Brazil
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5970
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0684
引用
收藏
页码：1292 / 1293
页数：2
相关论文
共 50 条
  • [21] Fat Mass and Resistin: Predictive Factors For Anti-TNF Therapy Response In Ankylosing Spondylitis Patients
    Saad, Carla G. S.
    Abreu, Andressa Silva
    Medeiros Ribeiro, Ana Cristina
    Moraes, Julio C. B.
    Perandini, Luiz A.
    Dassouki, Thalita
    Pereira, Rosa M. R.
    Bonfa, Eloisa
    Pinto, Ana Lucia S.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1058 - S1058
  • [22] EFFECT OF ETHNICITY ON RESPONSE TO ANTI-TNF BIOLOGIC THERAPY IN SEVERE ANKYLOSING SPONDYLITIS
    Aggrey-Fynn, G.
    Chagadama, D.
    Jawad, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1130 - 1130
  • [23] The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis
    Smith, N.
    Gadsby, K.
    Butt, S.
    Deighton, C.
    RHEUMATOLOGY, 2007, 46 (06) : 1044 - 1045
  • [24] SPINAL MEASUREMENTS TO MONITOR DISEASE PROGRESSION AND THE EFFECTS OF ANTI-TNF THERAPY IN ANKYLOSING SPONDYLITIS
    Corley, A. P.
    Isaacson, J.
    Gaston, J. S. H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 613 - 614
  • [25] Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Xenofon Baraliakos
    Joachim Listing
    Jan Brandt
    Martin Rudwaleit
    Joachim Sieper
    Juergen Braun
    Arthritis Research & Therapy, 7
  • [26] Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Baraliakos, X
    Listing, J
    Brandt, J
    Rudwaleit, M
    Sieper, J
    Braun, J
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) : R439 - R444
  • [27] Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis (AS) after 3 years of continous treatment with infliximab
    Baraliakos, X
    Brandt, J
    Listing, J
    Rudwaleit, M
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 413 - 413
  • [28] SCLEROSTIN DOES NOT PREDICT RADIOGRAPHIC PROGRESSION IN PATIENTS ON ANTI-TNF THERAPY - NEW RESULTS FROM THE EUROPEAN ANKYLOSING SPONDYLITIS (AS) INFLIXIMAB COHORT (EASIC)
    Baraliakos, X.
    Heldmann, F.
    Listing, P.
    Schett, G.
    van Verde, M.
    Appelboom, T.
    Brandt, J.
    van den Bosch, F.
    Breban, M.
    Burmester, G.
    Dougados, M.
    Emery, P.
    Gaston, H.
    Gruenke, M.
    van der Horst-Bruinsma, I
    van Tubergen, A.
    Leirisalo-Repo, M.
    Sieper, J.
    de Vlam, K.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 628 - 629
  • [29] Anti-TNF alpha therapy in ankylosing spondylitis. Can we predict a good clinical response?
    Rudwaleit, M
    Listing, J
    Brandt, J
    Braun, J
    Sieper, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S174 - S174
  • [30] SCLEROSTIN DOES NOT PREDICT RADIOGRAPHIC PROGRESSION IN PATIENTS ON ANTI-TNF THERAPY - NEW RESULTS FROM THE EUROPEAN ANKYLOSING SPONDYLITIS (AS) INFLIXIMAB COHORT (EASIC)
    Baraliakos, X.
    Heldmann, F.
    Listing, J.
    Schett, G.
    Appelboom, T.
    Brandt, J.
    van den Bosch, F.
    Breban, M.
    Burmester, G.
    Dougados, M.
    Emery, P.
    Gaston, H.
    Gruenke, M.
    van der Horst-Bruinsma, I.
    Landewe, R.
    Leirisalo-Repo, M.
    Sieper, J.
    de Vlam, K.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 243 - 243
12345